Bladder cancer

Bladder cancer is among the 3 or 4 most common tumours in Spain, and is the ninth in regard to diagnosis worldwide.

The average age of diagnosis is 70 years. The main risk factor is tobacco, which is responsible for 50% of all new diagnoses. The main symptom is the presence of blood in the urine, although this may have other causes.

Onkologikoa has a medical team of solid reputation when treating bladder cancer. Seeking to shorten the times taken to study, diagnose and treat the disease, it has the best resources available on the market. People who are patients, patients who are treated like people.

We'll call you

Call us if you prefer 0034943328000

Treatments for this kind of cancer

Non-muscle-invasive

TUR surgery

The objective is to remove the whole tumour in order to cure the patient. The risk of reappearance is high, meaning that the treatment consists of tumour resection by means of TUR. In some cases complementary treatment is necessary, which is administered directly into the bladder.

Muscle-invasive

Neoadjuvant chemotherapy

Chemotherapy prior to surgery followed by cystectomy (removal of the bladder) and lymphadenectomy (removal of the nodes near the bladder). When the transurethral resection confirms that the tumour is affecting the muscle layer, and the patient has no contraindications for chemotherapy, we administer 4 cycles of chemotherapy with Cisplatin-Gemcitabine, followed by surgery.

Muscle-invasive

Reconstruction of the urinary tract

Most often, reconstruction of the urinary tract is achieved by means of an ureterostomy, which consists of diverting the ureters to the skin of the abdomen through an opening. A plastic bag fixed to said opening with an adhesive is used to collect the urine, which is emptied periodically.

Enfermedad avanzada o metastásica

Quimioterapia

El objetivo del tratamiento es controlar o retrasar la aparición de síntomas y aumentar la supervivencia de los pacientes.
Los principales esquemas de quimioterapia que se emplean son combinaciones de dos fármacos, un platino (cisplatino, y cuando este esté contraindicado, carboplatino) con gemcitabina. En los casos en los que este tratamiento no funcione se puede valorar emplear otro tipo de quimioterapia como vinflunina o taxanos (Docetaxel, Paclitaxel).

Advanced of metastic disease

Immunotherapy

The basis of these treatments is to administer drugs to the patient which modulate the response of their own immune system to the tumour, so that their own defences become capable of eliminating the malignant cells. Three different drugs (Pembrolizumab, Atezolizumab and Novolumab) have already proven themselves to be active, and in some cases more so than classic chemotherapy.

We'll call you in 24 hours

Fill in your details and tell us why you're calling, so that we can deal with you in the most personal and efficient way possible.

You can call us too if you'd rather.

0034943328000